Thyroid eye disease medication Tepezza (teprotumumab) has recently been linked to an increase in hearing loss and other hearing problems like tinnitus. The first Tepezza lawsuit was filed in August 2022 and more are expected to follow. Patients claim that manufacturer Horizon Pharmaceuticals failed to…
A Texas couple recently filed a new Elmiron lawsuit in the U.S. District Court for the Eastern District of Pennsylvania. They claim that the wife used Elmiron (pentosan polysulfate sodium or PPS) to treat her interstitial cystitis (IC) and bladder pain, and then suffered from…
An Alabama woman has filed a new Elmiron lawsuit in the U.S. District Court for the Northern District of Alabama. She claims that after taking the medication, she suffered from serious injuries. Plaintiff Takes Elmiron for Years, Then Diagnosed with Permanent Retinal Injury According to…
Two plaintiffs recently filed new lawsuits against the makers of the antacid drug Zantac, seeking to hold them liable for injuries suffered after years of medication use. Pennsylvania Man Blames Zantac for Bladder Cancer The second plaintiff is from Pennsylvania and filed his case in…
On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the immediate withdrawal of all Zantac (ranitidine) products from the market. The agency took this action after independent studies revealed that the products could contain N-nitrosodimethylamine (NDMA), a probable human carcinogen and that…
A Delaware health insurance company recently filed a new metformin class-action lawsuit against manufacturer Aurobindo Pharma and others to recover payments made for the defendants’ “contaminated and adulterated metformin drugs.” The plaintiff seeks to represent other similarly situated healthcare insurers who had to pay the…
After online pharmacy Valisure found toxic chemical N-nitrosodimethylamine (NDMA) in samples of Zantac (ranitidine), it sent a citizen’s petition to the U.S. Food and Drug Administration (FDA) requesting a recall of all forms of the acid-reducing drug. The FDA conducted its own tests, found similar…
A Virginia woman recently filed a new Zantac lawsuit in the U.S. District Court for the District of New Jersey. The woman claims that after taking the drug for several years, she suffered serious injuries, and she seeks to hold the defendants liable for damages,…
When online pharmacy Valisure first found cancer-causing N-nitrosodimethylamine (NDMA) in Zantac, it informed the Food and Drug Administration (FDA) that the carcinogen was not an impurity, but rather, a result of an unstable ranitidine molecule. The company noted that because of this, every type or…
A California man recently filed a new Zantac lawsuit in the U.S. District Court for the Southern District of California. He claims that after taking the acid-reducing drug for about eight years, he suffered serious injuries. He seeks both compensatory and punitive damages. Plaintiff Takes…
